Clinical trials
Phase 2 Pancreatic Neoplasms trials in Singapore
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 4 |
| 2015 | 2 |
| 2017 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Apollomics Inc. | 1 |
| Boehringer Ingelheim | 1 |
| National Cancer Centre, Singapore | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Partner Therapeutics, Inc. | 1 |
| University of Miami | 1 |
| pSiMedica Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 11 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Brain Neoplasms | 2 |
| Carcinoma, Renal Cell | 2 |
| Head and Neck Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
| Biliary Tract Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.